Skip to content

BLUEPRINT MEDICINES CORPORATION

CIK 0001597264

← back to feed
Revenue (TTM)
$20.75M
−79.8% YoY Q1 Apr 2025
Net Income (TTM)
−$16.64M
+86.8% YoY Q1 Apr 2025
EPS Diluted (TTM)
−$0.28
+87.2% YoY Q1 Apr 2025
Gross Margin
25.2%
Q1 Apr 2025
Operating Margin
—
Q1 Apr 2025
Net Margin
-80.2%
Q1 Apr 2025
Free Cash Flow (TTM)
−$418.35M
Q1 Apr 2025
Cash
$122.25M
Q1 Apr 2025
Total Debt
$171.25M
Q1 Apr 2025
Shares Outstanding
64.58M sh
Q1 Apr 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings